Ignite Creation Date:
2024-05-06 @ 7:07 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05890547
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-06-06
First Post:
2023-06-02
Brief Title:
Recurrent Salivary Gland Infections in Covid-19
Sponsor:
Benha University
Organization:
Benha University
Study Overview
Official Title:
Recurrent Salivary Gland Infections in Covid-19
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RecSalivary
Brief Summary:
The aim of this study is to find out the role of Covid-19 in salivary gland infection and its recurrence
Detailed Description:
This is a prospective clinical study of 60 patients The study will be performed in the Otolaryngology department Faculty of Medicine Benha University during the duration from June 2023 to December 2023
Inclusion criteria
Adult patients aged 18 years
Exclusion criteria
Patients with known autoimmune diseases
Diabetes Mellitus
History of cancer in the region of the head and neck or previous radio andor chemotherapy
History of facial nerve palsy
Oral and dental diseases including chronic sialadenitis or sialolithiasis
previous oral surgery
Patients were divided into two equal groups each of 30 patients according to the cause of infection Group 1 comprises 30 patients with Covid-19 infection representing the study group COVID-19 diagnosis will be based on a positive SARS-CoV-2 nasopharyngeal swab on real-time reverse transcription-polymerase chain reaction RT-PCR in the presence of clinical andor radiological signs and group 2 comprises of 30 patients with non-Covid-19 infection as a control group
All patients will be submitted to full ENT and intraoral clinical examination We will Compare both groups as regards patients characteristics risk factors etiology symptoms and rate of recurrence of sialadenitis
Inclusion criteria
Adult patients aged 18 years
Exclusion criteria
Patients with known autoimmune diseases
Diabetes Mellitus
History of cancer in the region of the head and neck or previous radio andor chemotherapy
History of facial nerve palsy
Oral and dental diseases including chronic sialadenitis or sialolithiasis
previous oral surgery
Patients were divided into two equal groups each of 30 patients according to the cause of infection Group 1 comprises 30 patients with Covid-19 infection representing the study group COVID-19 diagnosis will be based on a positive SARS-CoV-2 nasopharyngeal swab on real-time reverse transcription-polymerase chain reaction RT-PCR in the presence of clinical andor radiological signs and group 2 comprises of 30 patients with non-Covid-19 infection as a control group
All patients will be submitted to full ENT and intraoral clinical examination We will Compare both groups as regards patients characteristics risk factors etiology symptoms and rate of recurrence of sialadenitis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Benha university | OTHER | Benha university | None |